Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This online dedicated therapeutics peer review session is open to College members who are qualified independent prescribers or at the placement stage of an IP qualification.

This online dedicated therapeutics peer review session is open to College members who are qualified independent prescribers or at the placement stage of an IP qualification.

We are looking for an IP qualified hospital optometrist and ophthalmic pharmacist to join our Clinical Management Guidelines (CMGs) review group to ensure that they are up-to-date, evidence based and accessible.